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Kaposi's Sarcoma With a
Non-Hodgkin's Lymphoma
Its Association in a Male Homosexual
With Human T-Cell Lymphotropic Virus
Type III Infection
Harold P. Katner, MD; George A. Pankey, MD;
Morris A. Flaum, MD; Joseph R. Dalovisio, MD;
Laurence M. Cortez, MD; Richard D. DeShazo, MD
\s=b\Combined tumor syndromes, specifically reticuloen-
dothelial malignancies and Kaposi's sarcoma, have long been
recognized. With the recognition of the acquired immunodefi-
ciency syndrome (AIDS), several patients with concurrent non\x=req-\
Hodgkin's lymphoma and Kaposi's sarcoma have been re-
ported at high risk for developing AIDS. The present Centers
for Disease Control definition of AIDS excludes these patients
on the assumption that one tumor is affecting the cellular
immunity, allowing for the development of the second malig-
nancy. In evaluating such a patient who had serologic evidence
of human T-cell lymphotropic virus type III infection, the
probable cause of AIDS, we have reviewed reports of patients
with similar concurrent malignancies before and since the
onset of the AIDS epidemic. We conclude that patients in high\x=req-\
risk groups for AIDS who develop similar combined tumor
syndromes should be classified as having AIDS.(Arch Intern Med 1986;146:393-394)
"IXTith the recognition of the acquired immunodeficiency
'
"
syndrome, a number of authors have documented the
association of reticuloendothelial neoplasms associated
with Kaposi's sarcoma in homosexual men. We present a
case of non-Hodgkin's lymphoma and Kaposi's sarcoma in a
homosexual man with serologie evidence of human T-cell
lymphotropic virus type III (HTLV-III) infection and argue
for the inclusion of these patients in the present Centers for
Disease Control surveillance definition.
REPORT OF A CASE
The patient was a 26-year-old male homosexual who had noted
the onset of generalized lymphadenopathy two years prior to the
time of hospital admission. An occipital node biopsy specimen
revealed nonspecific changes. His lymphadenopathy persisted. In
June 1983, he noted weight loss, polydipsia, polyuria, night sweats,
and fever. By mid-July the patient had developed hoarseness,
dysphagia associated with a cough productive of blood-tinged
saliva, and weakness and dyspnea on exertion. He was admitted to
the Ochsner Foundation Hospital, New Orleans, on July 20,1983.
Physical examination revealed a cachectic man with a blood
pressure of 104/50 mm Hg, a pulse rate 120 beats per minute, an oral
temperature of 36.8 °C, and a respiratory rate of 18/min. He had a
massive submucosal hemorrhage of his posterior pharynx. Tachy¬
cardia, with an S4 gallop, a grade 1/6 systolic ejection murmur,
decreased breath sounds in both posterior lung fields, and
hepatosplenomegaly were present. Firm, matted, nontender,
lymph nodes measuring up to 2  3 cm were noted bilaterally in the
occipital, cervical, supraclavicular, axillary, and inguinal areas.
His white blood cell count was 27,800/cu mm, with 52% poly-
morphonuclear cells, 22% band forms, 1% metamyelocytes, 2%
myelocytes, 18% lymphocytes, 4% monocytes, and 1% basophils.
The hemoglobin level was 4.6 g/dL, and the platelet count was
23,000/cu mm. Reticulocyte count was 9%, direct and indirect
Coombs' tests were positive, and the haptoglobin value was
decreased. The prothrombin time and the partial thromboplastin
time were normal, but his bleeding time was greater than 15
minutes. T-cell studies revealed a decreased T-helper/inducer to
suppressor/cytotoxic cell ratio of 0.71 resulting primarily from
decreased helper/inducer T-lymphocytes. The rapid plasma reagin
was reactive at a dilution of 1:16. Immunoelectrophoresis revealed
an elevated IgG level in a polyclonal pattern. A chest roent-
genogram revealed bilateral pleural effusions.
Bone marrow aspirate and a biopsy specimen revealed a hyper-
Patients With Concurrent Malignancies at Risk for Developing AIDS*
Source Patient Age, yr Tumor Types
Longevity From Date of
Diagnosis of Lymphoma
Ciobanu et al2 33 Kaposi's sarcoma; preleukemic stage
or a lymphoblastic neoplasia
1 mo
Perlow et al3 31 Kaposi's sarcoma; unclassified malignant
lymphoproliferative disorder
2 days
Chaganti et al" 39 Kaposi's sarcoma; diffuse malignant
Burkitt's lymphoma
Ziegler et al5 38
39
37
40
31
Kaposi's sarcoma; undifferentiated
lymphoma
Kaposi's sarcoma; undifferentiated
lymphoma
Kaposi's sarcoma; immunoblastic
sarcoma
Kaposi's sarcoma; immunoblastic
sarcoma of the brain
Kaposi's sarcoma; diffuse mixed
lymphoma
4 mo
Autopsy diagnosis
3 mo
Autopsy diagnosis
Figlin et al6 31 Kaposi's sarcoma; large-cell,
immunoblastic lymphoma
Approximately 3 mo
Present study 26 Kaposi's sarcoma; large-cell,
B-cell lymphoma
2V2 wk
*AIDS indicates acquired immunodeficiency syndrome. All patients were homosexual men.
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cellularity with adequate to increased megakaryocytes. The
stroma had a washed-out, fibrinous background with an absence of
fat in some areas. All myeloid elements were well represented.
Granulocytic hyperplasia with a predominance of immature forms
was present. There was an increase in reticulin, with a slight
amount of mild reticulin fibrosis. Special stains identified no acid-
fast or fungal organisms and none grew from culture. An echo-
virus" was eventually isolated from culture of the bone marrow.
Cytologie study of the pleural fluid was positive for class 5
malignant lymphoma. Appropriate stains and cultures for my-
cobacteria and bacteria were negative on both thoracentesis and
cerebrospinal fluids. Candida albicans subsequently grew from
the pleural fluid and sputum. Mycobacterium avium in¬
tracellulare was also isolated from sputum.
Because of progressive thrombocytopenia and bleeding unre¬
sponsive to transfusion and prednisone therapy, a splenectomy was
performed on July 26. At surgery, both the liver and intra-
abdominal lymph nodes were noted to be enlarged.
Histologically the spleen had two distinct lesions present. There
were multiple foci of nodular aggregates of large, noncleaved
lymphoma cells, many with relatively abundant eosinophilic
cytoplasm. Aggregates of Kaposi's sarcoma were also present.
After an initial rise in the platelet count following splenectomy
and 2 mg of vincristine sulfate, it fell to preoperative levels.
Cyclophosphamide, intravenous 7-immunogiobulin, vincristine-
loaded platelets, and danazol (Danocrine) were subsequently tried
but without response. The patient died on Aug 10, 1983.
An autopsy revealed extensive Kaposi's sarcoma and diffuse
histiocytic lymphoma involving widespread lymph nodes, the
gastrointestinal tract, and the mediastinal and retroperitoneal
connective tissue. Immunoperoxidase staining of the spleen re¬
vealed the lymphoma to be of B-cell origin, expressing mono-
clonality for IgM and 7 light chains. Serum sent for HTLV-III
serologie study was 3 + by the latex agglutination method.
COMMENT
The presence of a coexistent tumor excludes patients
from the present AIDS surveillance definition on the
assumption that one tumor has affected the patient's immu¬
nity in such a manner to allow for the development of a
second malignancy.1 Recently, however, a number of au¬
thors have reported simultaneously occurring reticuloen-
dothelial neoplasms and Kaposi's sarcoma in patients at
risk for developing AIDS (Table). With the isolation of
HTLV-III7 as the probable cause for AIDS, serologie mark¬
ers became available. The demonstration of serologie evi¬
dence of this infection in our patient, we believe, confirms
the diagnosis of this syndrome. We conclude that patients
with simultaneously occurring reticuloendothelial neo¬
plasms and Kaposi's sarcoma who are at risk for developing
AIDS should be included in the present definition of AIDS
for surveillance purposes.
Since this report was submitted, the Centers for Disease
Control has adopted in the case definition of AIDS, non-
Hodgkin's lymphoma ofhigh-grade pathologic type (diffuse,
undifferentiated) and of B-cell or unknown immunologie
phenotype, diagnosed by biopsy, if the patient has a positive
serologie or virologie test for HTLV-III.8
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Life-Threatening Cat-Scratch Disease
in an Immunocompromised Host
John R. Black, MD; Deirdre A. Herrington, MD;
Ted L. Hadfield, PhD; Douglas J. Wear, MD;
Andrew M. Margileth, MD; Brian Shigekawa, PhD
\s=b\We describe a renal allograft recipient with cat-scratch
disease in whom refractory hypotension, severe metabolic
acidosis, pulmonary infiltrates, and encephalopathy devel-
oped. The patient first presented with a history of cat bites and
scratches, fever, headache, and arthralgias. Four weeks later,
the clinical presentation of septic shock suddenly developed
in the patient. Cat-scratch disease was documented clinically
and by finding delicate pleomorphic bacilli in Warthin-Starry
silver stains of biopsy specimens taken from the primary
inoculation site and regional lymph node. The administration
of intravenous sulfamethoxazole and trimethoprim, erythro-
mycin lactobionate, and tobramycin sulfate therapy correlated
with recovery. Although cat-scratch disease is usually a
benign, self-limited illness, this article illustrates its systemic
nature, its potential for devastating complications in the immu-
nocompromised host, and its possible response to vigorous
antibiotic therapy.(Arch Intern Med 1986;146:394-396)
/^at-scratch disease (CSD) is the most common cause of
^ chronic regional lymphadenitis in children.1 It usually
produces a mild, self-limited illness. Typically, a cat scratch
or bite is followed in seven to 12 days (normal range, three to
50 days) by a papule or pustule at the site of the injury.
Regional lymphadenopathy, most commonly in the head,
neck, and/or axilla, appears within six or seven weeks.
These enlarged lymph nodes are tender in 80% of patients.
They may suppurate, but generally regress within two to
four months. Constitutional symptoms such as fever and
malaise are found in about one third of patients.1 Unusual
manifestations of CSD include encephalitis,2 osteolytic le¬
sion,3 mesenteric adenitis,4 pneumonitis,5 nonthrombocyto-
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